miércoles, 31 de agosto de 2016

ZONA DE SALUD DE OFRA: Píldoras, el Blog de la Saludteca. ¿Demasiada medi...

ZONA DE SALUD DE OFRA: Píldoras, el Blog de la Saludteca. ¿Demasiada medi...: El uso de demasiada medicina ( too much medicine ) es un problema reconocido cada vez mayor, y una manifestación de ello es la polifarmacia...

Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, and Assessment of Risk of Pediatric Hypertension

https://drive.google.com/file/d/0B1WvYV4qW93hbFhCbDZNUXVOVUE/view?usp=sharing

GUIA NICE SOSPECHA DE SEPSIS

https://drive.google.com/file/d/0B1WvYV4qW93hWEx4SmswbDBHOTg/view?usp=sharing

martes, 30 de agosto de 2016

Telemedicina e infarto agudo de miocardi

Effects of Interactive Patient Smartphone Support App on Drug Adherence and Lifestyle Changes in Myocardial Infarction Patients

A Randomized Study

Nina Johnston, MD, PhD; Johan Bodegard, MD, PhD; Susanna Jerström, MSc; Johanna Åkesson, MSc; Hilja Brorsson; Joakim Alfredsson, MD, PhD; Per A. Albertsson, MD, PhD; Jan-Erik Karlsson, MD, PhD; Christoph Varenhorst, MD, PhD

Disclosures

Am Heart J. 2016;178:85-94.

Abstract and Introduction
Methods
Results
Discussion
Conclusion

References

Abstract and Introduction

Abstract

Background Patients with myocardial infarction (MI) seldom reach recommended targets for secondary prevention. This study evaluated a smartphone application ("app") aimed at improving treatment adherence and cardiovascular lifestyle in MI patients.

Design Multicenter, randomized trial.

Methods A total of 174 ticagrelor-treated MI patients were randomized to either an interactive patient support tool (active group) or a simplified tool (control group) in addition to usual post-MI care. Primary end point was a composite nonadherence score measuring patient-registered ticagrelor adherence, defined as a combination of adherence failure events (2 missed doses registered in 7-day cycles) and treatment gaps (4 consecutive missed doses). Secondary end points included change in cardiovascular risk factors, quality of life (European Quality of Life–5 Dimensions), and patient device satisfaction (System Usability Scale).

Results Patient mean age was 58 years, 81% were men, and 21% were current smokers. At 6 months, greater patient-registered drug adherence was achieved in the active vs the control group (nonadherence score: 16.6 vs 22.8 [P = .025]). Numerically, the active group was associated with higher degree of smoking cessation, increased physical activity, and change in quality of life; however, this did not reach statistical significance. Patient satisfaction was significantly higher in the active vs the control group (system usability score: 87.3 vs 78.1 [P = .001]).

Conclusions In MI patients, use of an interactive patient support tool improved patient self-reported drug adherence and may be associated with a trend toward improved cardiovascular lifestyle changes and quality of life. Use of a disease-specific interactive patient support tool may be an appreciated, simple, and promising complement to standard secondary prevention.